Anaphylactoid reaction to imiglucerase, but not to alglucerase, in a type I gaucher patient

Blood Cells, Molecules, and Diseases

Volumn 25, Issue 2, 1999, Pages 92-94

  Aviner, S ^a   Levy, Y ^a   Yaniv, I ^a   Cohen, I J ^a  

^a NONE

Author keywords

Alglucerase; Anaphylactoid reaction; Gaucher disease; Sensitivity

Indexed keywords

ALGLUCERASE; DIPHENHYDRAMINE; IMIGLUCERASE; POLYGELINE;

ADULT; ANAPHYLAXIS; ARTICLE; BLEEDING; CASE REPORT; COUGHING; FLUSHING; GAUCHER DISEASE; HEART PALPITATION; HEPATOSPLENOMEGALY; HUMAN; HYPERHIDROSIS; MALE; MAST CELL DEGRANULATION; PRIORITY JOURNAL; TACHYCARDIA; THORAX PAIN; THROMBOCYTOPENIA;

EID: 0033064971     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1999.0231     Document Type: Article

References (10)

1. Brady R O. The sphingolipidoses. N Engl J Med. 275:1966;312-318.
2. Brady R O, Pentchev P G, Gal A E, Hibbert S R, Dekaban A S. Replacement therapy for inherited enzyme deficiency: use of purified glucocerebrosidase in Gaucher's disease. N Engl J Med. 324:1991;1464-1470.
3. Barton N W, Brady R O, Dambrosia J M. Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher disease. N Engl J Med. 324:1991;1464-1470.
4. Figuerosa M L, Rosenbloom B E, Kay A. A less costly regimen of alglucerase to treat Gaucher's disease. N Engl J Med. 324:1992;1632-1636.
5. Pastores G M, Sibille A R, Grabowski G A. Enzyme therapy in Gaucher disease type I: dosage, efficacy, and adverse events in 33 patients treated for 6 to 24 months. Blood. 82:1993;408-416.
6. Grabowski G A, Barton N W, Pastores G. Enzyme therapy in type I Gaucher disease: comparative efficacy of mannose terminated glucocerebrosidase from natural and recombinant sources. Ann Inter Med. 122:1995;33-39.
7. Richards S, Olson T A, McPherson J M. Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase. Blood. 82:1993;14042-1409.
8. Pone B E, Moskovitz J, Grabowski G. Enzyme therapy in Gaucher disease type I: effect of neutralizing antibodies to acid β-glucosidase. Blood. 90:1997;43-48.
9. Freeman M K. Fatal reaction to Haemaccel. Anesthesia. 34:1979;341-343.
10. Kraft D, Hedin H, Richter W, Schneider O. Immunoglobulin class and subclass distributor of dextran reactive antibodies in human reactors and nonreactors to clinical dextran. Allergy. 37:1982;481-489.